ASCO publishes a suite of peer-reviewed journals with content focused on
- clinical oncology research;
- issues and insights affecting oncology practice;
- cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources;
- biomedical informatics methods and processes applied to cancer-related data, information, and images; and
- the science and practice of precision oncology.
ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.
ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.
Publishing October 8, 2021, 4:00 pm ET:
Synovial Sarcoma in Children, Adolescents, and Young Adults: A report from the Children’s Oncology Group ARST0332 Study (Original Report)
Rajkumar Venkatramani, et al.
A Validated Risk Prediction Model for Breast Cancer in U.S. Black Women (Original Report)
Julie Palmer, et al.
Publishing October 7, 2021, 4:00 pm ET:
Integrated Molecular-Morphological Meningioma Classification: A Multicenter Retrospective Analysis, Retro- and Prospectively Validated (Original Report)
Felix Sahm, et al.
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the MRD Cohort of the Randomized Phase 2 CAPTIVATE Study (Original Report)
William Wierda, et al.
Breast Cancer Stage Is Associated With Exceeding Target Price in the Oncology Care Model (Original Contribution)
Valerie Csik, et al.
Communicating the Information Needed for Treatment Decision Making Among Patients With Pancreatic Cancer Receiving Preoperative Therapy (Original Contribution)
Howard Lee Jr, et al.
Publishing October 6, 2021, 4:00 pm ET:
Refining Patient-Centered Measures of End-of-Life Care Quality for Children With Cancer (Original Contribution)
Prasanna Ananth, et al.
Adopting Consensus Terms for Testing in Precision Medicine (Special Article)
Nikki Martin, et al.
Different Fumarate Hydratase (FH) Gene Variants are Associated with Distinct Cancer Phenotypes (Original Report)
Huma Rana, et al.
Published October 5, 2021, 4:00 pm ET:
Molecular Subgroup is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country (Original Report)
Nisreen Amayiri, et al.
Demographic and Clinical Outcomes of Brazilian Patients With Stage III or IV Non–Small- Cell Lung Cancer: Real-World Evidence Study on
the Basis of Deterministic Linkage Approach (Original Report)
Erica Regina Cerqueira, et al.
Published October 4, 2021, 4:00 pm ET:
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström’s Macroglobulinemia: Final Analysis From the Randomized Phase 3 iNNOVATETM Study (Original Report)
Christian Buske, et al.
Fertility Considerations for Reproductive- Aged Carriers of Deleterious BRCA Mutations: A Call for Early Intervention (Editorial)
Bat-Sheva Maslow, et al.
Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials (Original Contribution)
David Hui, et al.
Identifying Strategies for Robust Survivorship Program Implementation: A Qualitative Analysis of Cancer Programs (Original Contribution)
Soohyun Hwang, et al.
The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.